2019
DOI: 10.15761/icst.1000317
|View full text |Cite
|
Sign up to set email alerts
|

Immunity or morphogenesis in cancer development and treatment

Abstract: Non-selective cytotoxic therapy of cancer is effective, acting harmfully for a host. Legal deep lymphocytopenia at conventional cytotoxic therapy, high risk of new malignancies after it, spreading of malignant cells through favorite lymph nodes, a restriction of immunocytes activity inside tumor at anti-angiogenic treatment does not feet the idea of host immune defense against spontaneous cancer. To understand these theoretical inconsistencies we discussed the development of a tumor and its microvessels, gradu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 86 publications
(105 reference statements)
0
1
0
Order By: Relevance
“…Alas, a dominant convenient misconception continues to dictate that cancer can be nothing but an enemy, so the enemy is the target of immunity. In reality, most of the mechanisms of cells immunity in oncology reflect the activity of the main mechanism, which is morphogenesis with CD34, CD133 stem cells and their diverse descendants-progenitors of lymphoid lineage [126] [127]. They are the main targets today for the toxic therapy, which are based on indirect weakening of morphogenic support of a tumor.…”
Section: Deadly Competitionmentioning
confidence: 99%
“…Alas, a dominant convenient misconception continues to dictate that cancer can be nothing but an enemy, so the enemy is the target of immunity. In reality, most of the mechanisms of cells immunity in oncology reflect the activity of the main mechanism, which is morphogenesis with CD34, CD133 stem cells and their diverse descendants-progenitors of lymphoid lineage [126] [127]. They are the main targets today for the toxic therapy, which are based on indirect weakening of morphogenic support of a tumor.…”
Section: Deadly Competitionmentioning
confidence: 99%